论文部分内容阅读
目前脑梗塞的治疗方法较多,清栓酶、川芎嗪均在临床上广泛应用。我们曾用大剂量清栓酶、川芎嗪颈动脉注射治疗脑梗塞,取得较好的疗效,但因颈动脉反复穿刺常造成局部组织损伤硬结,且操作复杂,病人不易接受。因此,我们试用大剂量清栓酶快速静脉滴注联合大剂量川芎嗪静滴治疗急性脑梗塞,并与颈动脉注射法(对照组(1))与一般剂量清栓酶、川芎嗪静滴(对照组(2))对比,结果,观察组疗效略高于对照组(1),但疗效显著高于对照组(2),这在急性脑梗塞溶栓疗法中创出了一条新路,现报告如下。
The current treatment of cerebral infarction more, clear thrombin enzyme, ligustrazine are widely used in clinical practice. We have used large doses of clear thrombin, ligustrazine injection of carotid artery in the treatment of cerebral infarction, and achieved good results, but often caused by repeated carotid puncture local tissue injury induration, and the operation is complicated, the patient is not easy to accept. Therefore, we try to use high-dose bolting enzyme rapid intravenous infusion combined with large doses of ligustrazine intravenous infusion of acute cerebral infarction, and carotid artery injection (control group (1)) and the general dose of clear thrombin, ligustrazine intravenous infusion (2)), the results showed that the observation group was slightly higher than the control group (1), but the effect was significantly higher than the control group (2), which created a new road in the thrombolytic therapy for acute cerebral infarction The report is as follows.